Asthma is a chronic inflammatory disease that can become life-threatening if attacks are not controlled with medication. During an asthma attack, the airways narrow and fill with mucus, leading to symptoms such as coughing, shortness of breath, and wheezing.
Gut Microbiota is a complex ecosystem of microorganisms, including bacteria, viruses, fungi, and parasites, that inhabit the human intestinal tract. The number of microbes in the human body is estimated to be around 39 trillion, slightly exceeding the number of human cells. However, their genetic material is much richer and has a profound impact on bodily functions.
The microbiota performs many key functions, such as aiding digestion, synthesizing vitamins, protecting against pathogens, and supporting the immune system. A healthy microbiota is key to maintaining long-term health, whereas imbalances may trigger a wide range of diseases.
SIBO (Small Intestinal Bacterial Overgrowth) is a condition where bacteria that are normally present in small amounts in the small intestine—or that typically reside in the large intestine—begin to proliferate in the small intestine. SIBO disrupts normal digestion and nutrient absorption.
Symptoms of SIBO include bloating, abdominal pain, diarrhea, or constipation. However, it’s not just discomfort—SIBO can significantly impact quality of life, leading to chronic fatigue, skin issues, weight loss, and vitamin and mineral deficiencies. The underlying cause of SIBO is often another condition, and SIBO is a dysfunction of the gut that results from this primary issue.
Epstein-Barr virus (EBV) is a member of the herpesvirus group, most commonly associated with infectious mononucleosis. In the acute phase of the disease, EBV can cause severe symptoms such as high fever, sore throat, swollen lymph nodes, and fatigue, which significantly reduce the quality of life.
Effective treatment at this stage is important not only for alleviating symptoms but also for preventing complications and the progression of the infection into a chronic form. This article discusses approaches to symptomatic treatment of the acute phase of EBV infection, as well as other herpesvirus infections, taking into account their characteristics and factors influencing the success of therapy.
In the first part, we discussed therapies that can assist in treating pathogenic biofilms, most of which should be conducted in a specially equipped office and administered by a competent specialist. In the second part, we will consider therapies that can be performed at home, although they often involve prescription medications.
